$NVDA — BUY 📊 | 6 MONTHS THESIS

$NVDA — BUY 📊 | 6 MONTHS THESIS 🎯 FQ1 FY2027 (ends Apr) | reported May 20 | Rev $81.6B | EPS $1.87 vs $1.77 🟢 | Margin 69.0% 💡 Market prices in sharp deceleration from 85% revenue growth as hyperscaler capex peaks; we see sustained >50% DC growth through FY2027 driven by Blackwell volume, sovereign AI builds, and enterprise AI adoption, leading to further upward EPS revisions. 📉 Reward/risk: 2.5:1 🏢 Business Quality: 10/10 - monopolistic AI GPU leadership, 75% gross margins, massive R&D scale, and ecosystem lock-in that widens with every product cycle. 📊 Valuation: cheap to fair — 30.6x trailing PE at historical median, 27.7x forward PE for 85% revenue growth implies PEG <0.5; EV/EBITDA ~23x on >50% EBITDA... 🔮 Catalyst: Q2 FY2027 earnings report (expected late August 2026) with Blackwell-driven DC revenue and Q3 guidance 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/NVDA0617

🎯 FQ1 FY2027 (ends Apr) | reported May 20 | Rev $81.6B | EPS $1.87 vs $1.77 🟢 | Margin 69.0%